Company Overview and News

5
The Nest Egg Portfolio: The PostNL Dividend Yield Has Now Increased To 8.1%.

2018-08-19 seekingalpha - 1
Postal companies are still being ignored (or punished) by the market. Sometimes that’s deserved, but other times it seems to be more sentiment-based than fundamentals based. Yes, the ‘normal’ old-school post market is shrinking, but companies have been trying to tap into new sources of revenue (CTT Correios de Portugal (OTC:CTTPY) has started a bank), or are trying to improving the sorting and handling system to increase the volume of parcels.
DB FLOW XOM RDSB OCI RDSA WRDEF HIBRF BINCY CTTPY OCINF MBSRF RYDAF BPOSY BT.A RDS.B RDS.A MBSRY BTGOF ATASF BT BPOSF HBRN ATASY RYDBF FLTDF

2
PRESS DIGEST- British Business - Aug 15

2018-08-15 reuters
Aug 15 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
BT.A ROYMF ROYMY BTGOF RMG INTC BT

5
Google ads will be targeting a billboard near you: Alex Webb

2018-08-11 theedgemarkets
(Aug 10): Google may be about to pair all that data it has on users' web browsing with the ads displayed on public billboards. Creepy? Maybe. Inevitable? Almost certainly.
BT.A FB GOOGL BTGOF GOOG BT

 
England's Top Soccer League Scrambles to Secure Asian TV Deals - Bloomberg

2018-08-10 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
BT.A BTGOF MANU BT

 
England's Top Soccer League Scrambles to Secure Asian TV Deals

2018-08-09 theedgemarkets
(Aug 10): England’s Premier League is rushing to secure TV deals for some of the competition’s biggest Asian markets ahead of the season’s start on Friday, after financial problems at a rights agency threatened to prevent games being shown.
BT.A BTGOF MANU BT

1
RPT-Huawei in British spotlight over use of U.S. firm's software

2018-08-06 reuters
LONDON/SAN FRANCISCO, Aug 5 (Reuters) - Huawei Technologies is facing increased scrutiny in Britain because it is using an ageing software component sold by a firm based in the United States, one of the countries where lawmakers allege its equipment could facilitate Chinese spying, sources told Reuters.
BT.A VOD VOD VODPF BTGOF BT

1
Huawei in British spotlight over use of ageing US firm#39;s software

2018-08-06 moneycontrol
Huawei Technologies is facing increased scrutiny in Britain because it is using an ageing software component sold by a firm based in the US, one of the countries where lawmakers allege its equipment could facilitate Chinese spying, sources told Reuters.
BT.A VOD VOD VODPF BTGOF BT

1
Huawei in British spotlight over use of US firm's software

2018-08-06 channelnewsasia
LONDON/SAN FRANCISCO: Huawei Technologies is facing increased scrutiny in Britain because it is using an aging software component sold by a firm based in the United States, one of the countries where lawmakers allege its equipment could facilitate Chinese spying, sources told Reuters.
BT.A VOD VOD VODPF BTGOF BT

1
Huawei in British spotlight over use of U.S. firm's software

2018-08-05 reuters
LONDON/SAN FRANCISCO (Reuters) - Huawei Technologies [HWT.UL] is facing increased scrutiny in Britain because it is using an aging software component sold by a firm based in the United States, one of the countries where lawmakers allege its equipment could facilitate Chinese spying, sources told Reuters.
BT.A VOD VOD VODPF BTGOF BT

1
Huawei in British spotlight over use of US firm's software

2018-08-05 channelnewsasia
Huawei Technologies is facing increased scrutiny in Britain because it is using an aging software component sold by a firm based in the United States, one of the countries where lawmakers allege its equipment could facilitate Chinese spying, sources told Reuters.
BT.A VOD VOD VODPF BTGOF BT

 
BT Group: Almost No Surprises For Q1 2019

2018-07-30 seekingalpha
BT Group has delivered results as expected and maintained its outlook for the full year. In addition, the company continues to execute according to its strategy.
BT.A BTGOF BT

 
BT's quarterly revenues fall but earnings rise after slashing costs

2018-07-27 proactiveinvestors.com.au
BT Group plc (LON:BT.A) reported a 2% drop in first-quarter revenue, reflecting another weak performance in its enterprise businesses and tighter price controls by the regulator.
HL BT.A HRGLY HRGLF BTGOF BT

3
UPDATE 1-UK Stocks-Factors to watch on July 27

2018-07-27 reuters
July 27 (Reuters) - Britain’s FTSE 100 index is seen opening 20 points higher at 7,684 on Friday, according to financial bookmakers, with futures up 0.28 percent ahead of the cash market open.
BT.A BLT BHPBF BTGOF BP BP.A BP.B BT BP BHP BBL BHP BPAQF BHPLF CNKS

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

16h - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

17h - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

18h - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...